LETROZOL 2,5 MG COM REV CT BL AL PLAS PVC/PVDC X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1553700740021 -
GGREM
538020010029207 -
Código de barras
7898932797302
O que a fonte publica
- Detentor do registro
- ACCORD FARMACÊUTICA LTDA
- Princípios ativos
- LETROZOL
- Embalagem
- 2,5 MG COM REV CT BL AL PLAS PVC/PVDC X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Genérico
- Classe terapêutica
- L2B3 - CITOSTÁTICOS INIBIDORES DA AROMATASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "LETROZOL 2,5 MG COM REV CT BL AL PLAS PVC/PVDC X 30",
"holder": "ACCORD FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898932797302"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "538020010029207",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "64.171.697/0001-46",
"priceRegime": "Regulado",
"productName": "LETROZOL",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "2,5 MG COM REV CT BL AL PLAS PVC/PVDC X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "682.59",
"icms-12": "775.67",
"icms-17": "822.40",
"icms-18": "832.43",
"icms-19": "842.70",
"icms-20": "853.24",
"icms-21": "864.04",
"icms-22": "875.12",
"icms-23": "886.48",
"icms-17.5": "827.38",
"icms-19.5": "847.94",
"icms-20.5": "858.60",
"icms-22.5": "880.76",
"icms-12-alc": "766.36",
"icms-17-alc": "812.53",
"icms-18-alc": "822.44",
"icms-19-alc": "832.59",
"icms-20-alc": "843.00",
"icms-21-alc": "853.67",
"icms-22-alc": "864.61",
"icms-23-alc": "875.84",
"withoutTaxes": "674.40",
"icms-17.5-alc": "817.45",
"icms-19.5-alc": "837.76",
"icms-20.5-alc": "848.30",
"icms-22.5-alc": "870.19"
},
"pisCofinsList": "Positiva",
"substanceText": "LETROZOL",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "940.88",
"icms-12": "1069.18",
"icms-17": "1133.59",
"icms-18": "1147.42",
"icms-19": "1161.57",
"icms-20": "1176.10",
"icms-21": "1190.99",
"icms-22": "1206.26",
"icms-23": "1221.92",
"icms-17.5": "1140.46",
"icms-19.5": "1168.80",
"icms-20.5": "1183.49",
"icms-22.5": "1214.04",
"icms-12-alc": "1059.45",
"icms-17-alc": "1123.28",
"icms-18-alc": "1136.98",
"icms-19-alc": "1151.01",
"icms-20-alc": "1165.40",
"icms-21-alc": "1180.15",
"icms-22-alc": "1195.27",
"icms-23-alc": "1210.80",
"withoutTaxes": "932.32",
"icms-17.5-alc": "1130.08",
"icms-19.5-alc": "1158.15",
"icms-20.5-alc": "1172.72",
"icms-22.5-alc": "1202.99"
},
"invalidBarcodes": [],
"activeSubstances": [
"LETROZOL"
],
"therapeuticClass": "L2B3 - CITOSTÁTICOS INIBIDORES DA AROMATASE",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1553700740021",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L2B3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:538020010029207"